Viemed Healthcare (VMD) has completed the previously disclosed acquisition of Illinois-based Lehan’s Medical Equipment for a base purchase price of $26M, subject to customary adjustments, plus estimated contingent payments of $2.2M. In 2024, Lehan generated net revenues of approximately $25.7M and Adjusted EBITDA of approximately $7.4M. Viemed funded the acquisition through a combination of cash on hand and borrowings from its existing credit facilities. Viemed anticipates increasing its previously issued full-year 2025 guidance range to account for the expected contribution from this acquisition when it reports earnings results for the quarter ended June 30.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VMD:
- Viemed Healthcare Announces Share Repurchase Program
- Viemed Healthcare board authorizes share repurchase program up to 5%
- Viemed Healthcare Shareholders Approve Key Decisions at Meeting
- Viemed Healthcare to Present at East Coast IDEAS Investor Conference
- Viemed Healthcare’s Earnings Call Highlights Growth and Challenges